Product Code: TMRGL41003
TMR's report on the global neurovascular catheter market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global neurovascular catheter market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurovascular catheter market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the neurovascular catheter market.
The report delves into the competitive landscape of the global neurovascular catheter market. Key players operating in the global neurovascular catheter market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurovascular catheter market profiled in this report.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Investment Feasibility Matrix
- 3.4. Value Chain Analysis
- 3.5. PESTLE and Porter's Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
4. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032
- 5.3.1. Microcatheters
- 5.3.2. Balloon Catheters
- 5.3.3. Access Catheters
- 5.3.4. Embolization Catheters
- 5.3.5. Other types
- 5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
6. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032
- 6.3.1. Hospitals
- 6.3.2. Clinics
- 6.3.3. Ambulatory Surgical Centers
- 6.3.4. Diagnostic Centers
- 6.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
7. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
- 7.3.1. Embolic Stroke
- 7.3.2. Brain Aneurysm
- 7.3.3. Arteriovenous Malformations
- 7.3.4. Other Applications
- 7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By Application, 2022-2032
8. Global Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 8.1. Introduction
- 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. East Asia
- 8.3.5. South Asia
- 8.3.6. Oceania
- 8.3.7. MEA
- 8.4. Market Attractiveness Analysis By Region
9. North America Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. U.S.
- 9.2.1.2. Canada
- 9.2.2. By Type
- 9.2.3. By End Use
- 9.2.4. By Application
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By End Use
- 9.3.4. By Application
- 9.4. Key Takeaways
10. Latin America Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Brazil
- 10.2.1.2. Mexico
- 10.2.1.3. Argentina
- 10.2.1.4. Chile
- 10.2.1.5. Peru
- 10.2.1.6. Rest of Latin America
- 10.2.2. By Type
- 10.2.3. By End Use
- 10.2.4. By Application
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By End Use
- 10.3.4. By Application
- 10.4. Key Takeaways
11. Europe Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. Germany
- 11.2.1.2. Italy
- 11.2.1.3. France
- 11.2.1.4. U.K.
- 11.2.1.5. Spain
- 11.2.1.6. Russia
- 11.2.1.7. BENELUX
- 11.2.1.8. Rest of Europe
- 11.2.2. By Type
- 11.2.3. By End Use
- 11.2.4. By Application
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Type
- 11.3.3. By End Use
- 11.3.4. By Application
- 11.4. Key Takeaways
12. East Asia Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. China
- 12.2.1.2. Japan
- 12.2.1.3. South Korea
- 12.2.2. By Type
- 12.2.3. By End Use
- 12.2.4. By Application
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Type
- 12.3.3. By End Use
- 12.3.4. By Application
- 12.4. Key Takeaways
14. South Asia Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. India
- 13.2.1.2. Thailand
- 13.2.1.3. Malaysia
- 13.2.1.4. Indonesia
- 13.2.1.5. Rest of South Asia
- 13.2.2. By Type
- 13.2.3. By End Use
- 13.2.4. By Application
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Type
- 13.3.3. By End Use
- 13.3.4. By Application
- 13.4. Key Takeaways
14. Oceania Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. Australia
- 14.2.1.2. New Zealand
- 14.2.2. By Type
- 14.2.3. By End Use
- 14.2.4. By Application
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Type
- 14.3.3. By End Use
- 14.3.4. By Application
- 14.4. Key Takeaways
15. MEA Neurovascular Catheters Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 15.2.1. By Country
- 15.2.1.1. GCC
- 15.2.1.2. Rest of MEA
- 15.2.2. By Type
- 15.2.3. By End Use
- 15.2.4. By Application
- 15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Type
- 15.3.3. By End Use
- 15.3.4. By Application
- 15.4. Key Takeaways
16. Key Countries Neurovascular Catheters Market Analysis
- 16.1. U.S.
- 16.1.1. Pricing Analysis
- 16.1.2. Market Share Analysis, 2021
- 16.1.2.1. By Type
- 16.1.2.2. By End Use
- 16.1.2.3. By Application
- 16.2. Canada
- 16.2.1. Pricing Analysis
- 16.2.2. Market Share Analysis, 2021
- 16.2.2.1. By Type
- 16.2.2.2. By End Use
- 16.2.2.3. By Application
- 16.3. Brazil
- 16.3.1. Pricing Analysis
- 16.3.2. Market Share Analysis, 2021
- 16.3.2.1. By Type
- 16.3.2.2. By End Use
- 16.3.2.3. By Application
- 16.4. Mexico
- 16.4.1. Pricing Analysis
- 16.4.2. Market Share Analysis, 2021
- 16.4.2.1. By Type
- 16.4.2.2. By End Use
- 16.4.2.3. By Application
- 16.5. Argentina
- 16.5.1. Pricing Analysis
- 16.5.2. Market Share Analysis, 2021
- 16.5.2.1. By Type
- 16.5.2.2. By End Use
- 16.5.2.3. By Application
- 16.6. Germany
- 16.6.1. Pricing Analysis
- 16.6.2. Market Share Analysis, 2021
- 16.6.2.1. By Type
- 16.6.2.2. By End Use
- 16.6.2.3. By Application
- 16.7. Italy
- 16.7.1. Pricing Analysis
- 16.7.2. Market Share Analysis, 2021
- 16.7.2.1. By Type
- 16.7.2.2. By End Use
- 16.7.2.3. By Application
- 16.8. France
- 16.8.1. Pricing Analysis
- 16.8.2. Market Share Analysis, 2021
- 16.8.2.1. By Type
- 16.8.2.2. By End Use
- 16.8.2.3. By Application
- 16.9. U.K.
- 16.9.1. Pricing Analysis
- 16.9.2. Market Share Analysis, 2021
- 16.9.2.1. By Type
- 16.9.2.2. By End Use
- 16.9.2.3. By Application
- 16.10. Spain
- 16.10.1. Pricing Analysis
- 16.10.2. Market Share Analysis, 2021
- 16.10.2.1. By Type
- 16.10.2.2. By End Use
- 16.10.2.3. By Application
- 16.11. Russia
- 16.11.1. Pricing Analysis
- 16.11.2. Market Share Analysis, 2021
- 16.11.2.1. By Type
- 16.11.2.2. By End Use
- 16.11.2.3. By Application
- 16.12. BENELUX
- 16.12.1. Pricing Analysis
- 16.12.2. Market Share Analysis, 2021
- 16.12.2.1. By Type
- 16.12.2.2. By End Use
- 16.12.2.3. By Application
- 16.13. China
- 16.13.1. Pricing Analysis
- 16.13.2. Market Share Analysis, 2021
- 16.13.2.1. By Type
- 16.13.2.2. By End Use
- 16.13.2.3. By Application
- 16.14. Japan
- 16.14.1. Pricing Analysis
- 16.14.2. Market Share Analysis, 2021
- 16.14.2.1. By Type
- 16.14.2.2. By End Use
- 16.14.2.3. By Application
- 16.15. South Korea
- 16.15.1. Pricing Analysis
- 16.15.2. Market Share Analysis, 2021
- 16.15.2.1. By Type
- 16.15.2.2. By End Use
- 16.15.2.3. By Application
- 16.16. India
- 16.16.1. Pricing Analysis
- 16.16.2. Market Share Analysis, 2021
- 16.16.2.1. By Type
- 16.16.2.2. By End Use
- 16.16.2.3. By Application
- 16.17. Thailand
- 16.17.1. Pricing Analysis
- 16.17.2. Market Share Analysis, 2021
- 16.17.2.1. By Type
- 16.17.2.2. By End Use
- 16.17.2.3. By Application
- 16.18. Malaysia
- 16.18.1. Pricing Analysis
- 16.18.2. Market Share Analysis, 2021
- 16.18.2.1. By Type
- 16.18.2.2. By End Use
- 16.18.2.3. By Application
- 16.19. Indonesia
- 16.19.1. Pricing Analysis
- 16.19.2. Market Share Analysis, 2021
- 16.19.2.1. By Type
- 16.19.2.2. By End Use
- 16.19.2.3. By Application
- 16.20. Australia
- 16.20.1. Pricing Analysis
- 16.20.2. Market Share Analysis, 2021
- 16.20.2.1. By Type
- 16.20.2.2. By End Use
- 16.20.2.3. By Application
- 16.21. New Zealand
- 16.21.1. Pricing Analysis
- 16.21.2. Market Share Analysis, 2021
- 16.21.2.1. By Type
- 16.21.2.2. By End Use
- 16.21.2.3. By Application
- 16.22. GCC Countries
- 16.22.1. Pricing Analysis
- 16.22.2. Market Share Analysis, 2021
- 16.22.2.1. By Type
- 16.22.2.2. By End Use
- 16.22.2.3. By Application
17. Market Structure Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Benchmarking
- 17.3. Market Share Analysis of Top Players
- 17.3.1. By Regional
- 17.3.2. By Type
- 17.3.3. By End Use
- 17.3.4. By Application
18. Competition Analysis
- 18.1. Competition Deep Dive
- 18.1.1. Medtronic
- 18.1.1.1. Overview
- 18.1.1.2. Product Portfolio
- 18.1.1.3. Profitability by Market Segments
- 18.1.1.4. Sales Footprint
- 18.1.1.5. Strategy Overview
- 18.1.1.5.1. Marketing Strategy
- 18.1.1.5.2. Product Strategy
- 18.1.1.5.3. Channel Strategy
- 18.1.2. BALT USA LLC
- 18.1.2.1. Overview
- 18.1.2.2. Product Portfolio
- 18.1.2.3. Profitability by Market Segments
- 18.1.2.4. Sales Footprint
- 18.1.2.5. Strategy Overview
- 18.1.2.5.1. Marketing Strategy
- 18.1.2.5.2. Product Strategy
- 18.1.2.5.3. Channel Strategy
- 18.1.3. DePuy Synthes
- 18.1.3.1. Overview
- 18.1.3.2. Product Portfolio
- 18.1.3.3. Profitability by Market Segments
- 18.1.3.4. Sales Footprint
- 18.1.3.5. Strategy Overview
- 18.1.3.5.1. Marketing Strategy
- 18.1.3.5.2. Product Strategy
- 18.1.3.5.3. Channel Strategy
- 18.1.4. Biomerics
- 18.1.4.1. Overview
- 18.1.4.2. Product Portfolio
- 18.1.4.3. Profitability by Market Segments
- 18.1.4.4. Sales Footprint
- 18.1.4.5. Strategy Overview
- 18.1.4.5.1. Marketing Strategy
- 18.1.4.5.2. Product Strategy
- 18.1.4.5.3. Channel Strategy
- 18.1.5. Zeus Indutsrial Products, INC.
- 18.1.5.1. Overview
- 18.1.5.2. Product Portfolio
- 18.1.5.3. Profitability by Market Segments
- 18.1.5.4. Sales Footprint
- 18.1.5.5. Strategy Overview
- 18.1.5.5.1. Marketing Strategy
- 18.1.5.5.2. Product Strategy
- 18.1.5.5.3. Channel Strategy
- 18.1.6. Raumedic AG
- 18.1.6.1. Overview
- 18.1.6.2. Product Portfolio
- 18.1.6.3. Profitability by Market Segments
- 18.1.6.4. Sales Footprint
- 18.1.6.5. Strategy Overview
- 18.1.6.5.1. Marketing Strategy
- 18.1.6.5.2. Product Strategy
- 18.1.6.5.3. Channel Strategy
- 18.1.7. Concentric Medical, Inc
- 18.1.7.1. Overview
- 18.1.7.2. Product Portfolio
- 18.1.7.3. Profitability by Market Segments
- 18.1.7.4. Sales Footprint
- 18.1.7.5. Strategy Overview
- 18.1.7.5.1. Marketing Strategy
- 18.1.7.5.2. Product Strategy
- 18.1.7.5.3. Channel Strategy
- 18.1.8. Creganna Medical
- 18.1.8.1. Overview
- 18.1.8.2. Product Portfolio
- 18.1.8.3. Profitability by Market Segments
- 18.1.8.4. Sales Footprint
- 18.1.8.5. Strategy Overview
- 18.1.8.5.1. Marketing Strategy
- 18.1.8.5.2. Product Strategy
- 18.1.8.5.3. Channel Strategy
- 18.1.9. Vegamedical.eu
- 18.1.91. Overview
- 18.1.9.2. Product Portfolio
- 18.1.9.3. Profitability by Market Segments
- 18.1.9.4. Sales Footprint
- 18.1.9.5. Strategy Overview
- 18.1.9.5.1. Marketing Strategy
- 18.1.9.5.2. Product Strategy
- 18.1.9.5.3. Channel Strategy
- 18.1.10. Stryker
- 18.1.10.1. Overview
- 18.1.10.2. Product Portfolio
- 18.1.10.3. Profitability by Market Segments
- 18.1.10.4. Sales Footprint
- 18.1.10.5. Strategy Overview
- 18.1.10.5.1. Marketing Strategy
- 18.1.10.5.2. Product Strategy
- 18.1.10.5.3. Channel Strategy
- 18.1.11. phenox GmbH
- 18.1.11.1. Overview
- 18.1.11.2. Product Portfolio
- 18.1.11.3. Profitability by Market Segments
- 18.1.11.4. Sales Footprint
- 18.1.11.5. Strategy Overview
- 18.1.11.5.1. Marketing Strategy
- 18.1.11.5.2. Product Strategy
- 18.1.11.5.3. Channel Strategy
- 18.1.12. Penumbra, Inc.
- 18.1.12.1. Overview
- 18.1.12.2. Product Portfolio
- 18.1.12.3. Profitability by Market Segments
- 18.1.12.4. Sales Footprint
- 18.1.12.5. Strategy Overview
- 18.1.12.5.1. Marketing Strategy
- 18.1.12.5.2. Product Strategy
- 18.1.12.5.3. Channel Strategy
- 18.1.13. Integer Holdings Corporation
- 18.1.13.1. Overview
- 18.1.13.2. Product Portfolio
- 18.1.13.3. Profitability by Market Segments
- 18.1.13.4. Sales Footprint
- 18.1.13.5. Strategy Overview
- 18.1.13.5.1. Marketing Strategy
- 18.1.13.5.2. Product Strategy
- 18.1.13.5.3. Channel Strategy
- 18.1.14. Terumo Corporation
- 18.1.14.1. Overview
- 18.1.14.2. Product Portfolio
- 18.1.14.3. Profitability by Market Segments
- 18.1.14.4. Sales Footprint
- 18.1.14.5. Strategy Overview
- 18.1.14.5.1. Marketing Strategy
- 18.1.14.5.2. Product Strategy
- 18.1.14.5.3. Channel Strategy
- 18.1.15. Integra LifeSciences Corporation
- 18.1.15.1. Overview
- 18.1.15.2. Product Portfolio
- 18.1.15.3. Profitability by Market Segments
- 18.1.15.4. Sales Footprint
- 18.1.15.5. Strategy Overview
- 18.1.15.5.1. Marketing Strategy
- 18.1.15.5.2. Product Strategy
- 18.1.15.5.3. Channel Strategy
- 18.1.16. Biomerics
- 18.1.16.1. Overview
- 18.1.16.2. Product Portfolio
- 18.1.16.3. Profitability by Market Segments
- 18.1.16.4. Sales Footprint
- 18.1.16.5. Strategy Overview
- 18.1.16.5.1. Marketing Strategy
- 18.1.16.5.2. Product Strategy
- 18.1.16.5.3. Channel Strategy
- 18.1.17. Acandis GmbH
- 18.1.17.1. Overview
- 18.1.17.2. Product Portfolio
- 18.1.17.3. Profitability by Market Segments
- 18.1.17.4. Sales Footprint
- 18.1.17.5. Strategy Overview
- 18.1.17.5.1. Marketing Strategy
- 18.1.17.5.2. Product Strategy
- 18.1.17.5.3. Channel Strategy
- 18.1.18. Teleflex Incorporated
- 18.1.18.1. Overview
- 18.1.18.2. Product Portfolio
- 18.1.18.3. Profitability by Market Segments
- 18.1.18.4. Sales Footprint
- 18.1.18.5. Strategy Overview
- 18.1.18.5.1. Marketing Strategy
- 18.1.18.5.2. Product Strategy
- 18.1.18.5.3. Channel Strategy
- 18.1.19. Microvention Inc.
- 18.1.19.1. Overview
- 18.1.19.2. Product Portfolio
- 18.1.19.3. Profitability by Market Segments
- 18.1.19.4. Sales Footprint
- 18.1.19.5. Strategy Overview
- 18.1.19.5.1. Marketing Strategy
- 18.1.19.5.2. Product Strategy
- 18.1.19.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology